XenTech

Biotechnology, Health Care, Life Science
Founded in 2006-01-01
Évry, Ile-de-France, France
For Profit

About XenTech

XenTech is an innovative biotech/CRO company specialized in the preclinical cancer drug efficacy evaluation and the identification of biomarkers and therapeutic targets. They offer a unique collection of patient-derived tumor xenografts

Company Metrics

  • Employees: 11-50
  • Monthly Visits: None
  • Tech Stack: None active products

Financial Information

  • Estimated Revenue: $1M to $10M
  • Total Funding: 600000 EUR
  • Last Funding: 600000 EUR (Seed)
  • Funding Status: Seed

Technology Stack

XenTech actively uses None products in their tech stack.

Market Presence

Industries: Biotechnology, Health Care, Life Science

Headquarters: Évry, Ile-de-France, France